<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02951806</url>
  </required_header>
  <id_info>
    <org_study_id>02/IRB/2016</org_study_id>
    <nct_id>NCT02951806</nct_id>
  </id_info>
  <brief_title>Effect of Slow Injection of Fentanyl on the Incidence of Spinal Anesthesia Induced Itching in Cesarean Section</brief_title>
  <official_title>Effect of Slow Injection of Fentanyl on the Incidence of Spinal Anesthesia Induced Itching in Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Soliman Fakeeh Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Soliman Fakeeh Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pruritus is a troublesome side-effect of neuraxial (epidural and intrathecal) opioids.&#xD;
      Sometimes it may be more unpleasant than pain itself. The incidence of pruritus is 83% in&#xD;
      postpartum patients and 69% in non-pregnant patients including males and females (1). Some&#xD;
      researchers concluded that slow injection rate of hyperbaric bupivacaine may be a simple and&#xD;
      effective way to reduce the incidence and severity of hypotension during cesarean section&#xD;
      under spinal anesthesia (2). In this new research I want to investigate the effect of slow&#xD;
      injection of fentanyl separately, in spinal anesthesia for cesarean section, on the incidence&#xD;
      of itching In this double blind randomized study two hundred parturient will be randomly&#xD;
      allocated in to two groups; Group (R) will receive 25 mic fentanyl spinal ( after dilution&#xD;
      with 2.5 ml CSF) in 15 seconds. Group (S) will receive the same dose in 90 seconds All&#xD;
      parturient will receive 10 mg bupivacaine in 45 min after fentanyl. Exclusion criteria will&#xD;
      be those with allergy to any medications, contraindications to spinal anesthesia, those who&#xD;
      requested sedation, presence of skin lesions that may cause itching and opioid addiction.&#xD;
&#xD;
      Parturient will be monitored regarding the incidence of itching, hypotension, nausea and&#xD;
      vomiting. Onset and level of sensory block will also be recorded.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Actual">June 2020</completion_date>
  <primary_completion_date type="Actual">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>( 0 - 10) Itching scale</measure>
    <time_frame>60 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfactory Block ( no pain, Pain relieved by opioids or pain needs general anesthesia</measure>
    <time_frame>60 min</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Hypotension ( yes or no)</measure>
    <time_frame>60 minutes</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">215</enrollment>
  <condition>Itching</condition>
  <arm_group>
    <arm_group_label>(R) Rapid spinal fentanyl injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive 25 mic fentanyl spinal ( after dilution with 2.5 ml CSF) in 15 seconds then 10 mg hyperbaric bupivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(S) Slow spinal fentanyl injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive 25 mic fentanyl spinal ( after dilution with 2.5 ml CSF) in 90 seconds then 10 mg hyperbaric bupivacaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>(R) Rapid spinal fentanyl injection</intervention_name>
    <description>Patients will receive 25 micrograms fentanyl ( after dilution with 2.5 ml CSF) in 20 seconds then 10 mg hyperbaric bupivacaine.</description>
    <arm_group_label>(R) Rapid spinal fentanyl injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>(S) Slow spinal fentanyl injection</intervention_name>
    <description>Patients will receive 25 micrograms fentanyl ( after dilution with 2.5 ml CSF) in 90 seconds then 10 mg hyperbaric bupivacaine.</description>
    <arm_group_label>(S) Slow spinal fentanyl injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective and emergency cesarean section parturient.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to any medications, contraindications to spinal anesthesia, those who&#xD;
             requested sedation, presence of skin lesions that may cause itching and opioid&#xD;
             addiction.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr A Keera</last_name>
    <role>Principal Investigator</role>
    <affiliation>Doctor Soliman Fakeeh Hospital</affiliation>
  </overall_official>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 19, 2016</study_first_submitted>
  <study_first_submitted_qc>October 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <last_update_submitted>September 5, 2020</last_update_submitted>
  <last_update_submitted_qc>September 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr. Soliman Fakeeh Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Amr Aly Ismail Keera</investigator_full_name>
    <investigator_title>Prof. Amr Aly Keera</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>I hope to publish the data in a respected journal.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

